Amy D. Proal

2.6k total citations · 2 hit papers
22 papers, 1.4k citations indexed

About

Amy D. Proal is a scholar working on Molecular Biology, Immunology and Psychiatry and Mental health. According to data from OpenAlex, Amy D. Proal has authored 22 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Immunology and 6 papers in Psychiatry and Mental health. Recurrent topics in Amy D. Proal's work include Fibromyalgia and Chronic Fatigue Syndrome Research (6 papers), Long-Term Effects of COVID-19 (5 papers) and Vitamin D Research Studies (3 papers). Amy D. Proal is often cited by papers focused on Fibromyalgia and Chronic Fatigue Syndrome Research (6 papers), Long-Term Effects of COVID-19 (5 papers) and Vitamin D Research Studies (3 papers). Amy D. Proal collaborates with scholars based in United States, Australia and United Kingdom. Amy D. Proal's co-authors include Michael B. VanElzakker, Trevor G Marshall, Paul Albert, Michael A. Fischbach, Philip Hugenholtz, Natalia Ivanova, Hila Sberro, David Páez-Espino, Nikos C. Kyrpides and Stephen Nayfach and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and The Journal of Immunology.

In The Last Decade

Amy D. Proal

21 papers receiving 1.3k citations

Hit Papers

Long COVID or Post-acute Sequelae of COVID-19 (PASC): An ... 2021 2026 2022 2024 2021 2021 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amy D. Proal United States 14 494 416 368 236 190 22 1.4k
David Zeman United States 24 138 0.3× 241 0.6× 351 1.0× 19 0.1× 76 0.4× 74 1.3k
Kathryn L. Howe Canada 17 140 0.3× 401 1.0× 178 0.5× 21 0.1× 47 0.2× 45 1.3k
Lan Hu China 11 93 0.2× 175 0.4× 279 0.8× 84 0.4× 32 0.2× 29 926
Tian Ming Tu Singapore 20 446 0.9× 148 0.4× 268 0.7× 19 0.1× 59 0.3× 43 1.3k
Holger Schmidt Germany 21 188 0.4× 190 0.5× 204 0.6× 46 0.2× 69 0.4× 58 1.3k
Xueyang Zhang China 15 357 0.7× 177 0.4× 286 0.8× 9 0.0× 46 0.2× 47 897
Milene Alvarenga Rachid Brazil 30 109 0.2× 500 1.2× 369 1.0× 23 0.1× 78 0.4× 123 2.4k
Karen Böhmwald Chile 17 413 0.8× 114 0.3× 472 1.3× 8 0.0× 36 0.2× 36 1.2k
Andreas Hiergeist Germany 19 70 0.1× 910 2.2× 305 0.8× 98 0.4× 32 0.2× 51 1.6k
Galileo Escobedo Mexico 21 61 0.1× 301 0.7× 147 0.4× 148 0.6× 19 0.1× 101 1.6k

Countries citing papers authored by Amy D. Proal

Since Specialization
Citations

This map shows the geographic impact of Amy D. Proal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy D. Proal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy D. Proal more than expected).

Fields of papers citing papers by Amy D. Proal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy D. Proal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy D. Proal. The network helps show where Amy D. Proal may publish in the future.

Co-authorship network of co-authors of Amy D. Proal

This figure shows the co-authorship network connecting the top 25 collaborators of Amy D. Proal. A scholar is included among the top collaborators of Amy D. Proal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy D. Proal. Amy D. Proal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Proal, Amy D. & Michael B. VanElzakker. (2025). Pathogens accelerate features of human aging: A review of molecular mechanisms. Ageing Research Reviews. 112. 102865–102865.
2.
Fallon, Brian A., Roberta L. DeBiasi, Sarah B. Mulkey, et al.. (2025). Proposed research classification criteria for Lyme disease in infection associated chronic illness studies. Frontiers in Medicine. 12. 1519163–1519163. 2 indexed citations
3.
Greene, Kerrie, Alexandra Tabachnikova, Bornali Bhattacharjee, et al.. (2025). Cerebrospinal fluid immune phenotyping reveals distinct immunotypes of myalgic encephalomyelitis/chronic fatigue syndrome. The Journal of Immunology. 214(7). 1539–1551. 2 indexed citations
4.
Tabacof, Laura, et al.. (2024). Distinguishing pain profiles among individuals with long COVID. SHILAP Revista de lepidopterología. 5. 1448816–1448816. 2 indexed citations
6.
Jang, Hyesun, Saibyasachi N. Choudhury, Yanbao Yu, et al.. (2023). Persistent immune and clotting dysfunction detected in saliva and blood plasma after COVID-19. Heliyon. 9(7). e17958–e17958. 8 indexed citations
7.
8.
Nunes, J. Massimo, Arneaux Kruger, Amy D. Proal, Douglas B. Kell, & Etheresia Pretorius. (2022). The Occurrence of Hyperactivated Platelets and Fibrinaloid Microclots in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). Pharmaceuticals. 15(8). 931–931. 42 indexed citations
9.
Nayfach, Stephen, David Páez-Espino, Soo Jen Low, et al.. (2021). Metagenomic compendium of 189,680 DNA viruses from the human gut microbiome. Nature Microbiology. 6(7). 960–970. 313 indexed citations breakdown →
10.
Proal, Amy D. & Michael B. VanElzakker. (2021). Long COVID or Post-acute Sequelae of COVID-19 (PASC): An Overview of Biological Factors That May Contribute to Persistent Symptoms. Frontiers in Microbiology. 12. 698169–698169. 550 indexed citations breakdown →
12.
Proal, Amy D. & Trevor G Marshall. (2018). Re-framing the theory of autoimmunity in the era of the microbiome: persistent pathogens, autoantibodies, and molecular mimicry.. PubMed. 25(140). 299–308. 14 indexed citations
13.
Proal, Amy D., Inge Lindseth, & Trevor G Marshall. (2017). Microbe-microbe and host-microbe interactions drive microbiome dysbiosis and inflammatory processes.. PubMed. 23(124). 51–60. 31 indexed citations
14.
Proal, Amy D., et al.. (2013). Immunostimulation in the treatment for chronic fatigue syndrome/myalgic encephalomyelitis. Immunologic Research. 56(2-3). 398–412. 13 indexed citations
15.
Proal, Amy D., Paul Albert, & Trevor G Marshall. (2013). The human microbiome and autoimmunity. Current Opinion in Rheumatology. 25(2). 234–240. 63 indexed citations
16.
Proal, Amy D., et al.. (2011). Immunostimulation in the era of the metagenome. Cellular and Molecular Immunology. 8(3). 213–225. 20 indexed citations
17.
Proal, Amy D., Paul Albert, & Trevor G Marshall. (2009). Autoimmune disease in the era of the metagenome. Autoimmunity Reviews. 8(8). 677–681. 43 indexed citations
18.
Albert, Paul, Amy D. Proal, & Trevor G Marshall. (2009). Vitamin D: The alternative hypothesis. Autoimmunity Reviews. 8(8). 639–644. 54 indexed citations
19.
Albert, Paul, et al.. (2009). Vitamin D Metabolites as Clinical Markers in Autoimmune and Chronic Disease. Annals of the New York Academy of Sciences. 1173(1). 384–390. 53 indexed citations
20.
Proal, Amy D., Paul Albert, & Trevor G Marshall. (2009). Dysregulation of the Vitamin D Nuclear Receptor May Contribute to the Higher Prevalence of Some Autoimmune Diseases in Women. Annals of the New York Academy of Sciences. 1173(1). 252–259. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026